RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 190 filers reported holding RECURSION PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,605,973 | +48.6% | 6,876,598 | +45.1% | 0.40% | +71.8% |
| Q2 2023 | $35,396,723 | +48.4% | 4,738,517 | +32.5% | 0.23% | +42.7% |
| Q1 2023 | $23,857,670 | -0.2% | 3,576,862 | +15.4% | 0.16% | -20.8% |
| Q4 2022 | $23,897,068 | -33.2% | 3,099,490 | -7.7% | 0.21% | -16.9% |
| Q3 2022 | $35,748,000 | +113.8% | 3,359,811 | +23.0% | 0.25% | +151.5% |
| Q2 2022 | $16,720,000 | -17.4% | 2,732,087 | -3.4% | 0.10% | +17.9% |
| Q1 2022 | $20,242,000 | -47.1% | 2,827,163 | +26.7% | 0.08% | -27.6% |
| Q4 2021 | $38,234,000 | -35.9% | 2,232,013 | -13.9% | 0.12% | -18.9% |
| Q3 2021 | $59,684,000 | -31.3% | 2,593,836 | +9.0% | 0.14% | -11.7% |
| Q2 2021 | $86,822,000 | – | 2,378,675 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Data Collective IV GP, LLC | 5,941,120 | $45,806,035 | 48.11% |
| Kinnevik AB (publ) | 7,653,061 | $59,005,100 | 33.28% |
| MV Management XI, L.L.C. | 1,971,908 | $15,203,411 | 26.45% |
| MIC Capital Management UK LLP | 8,451,758 | $65,163,057 | 12.86% |
| ArchPoint Investors | 1,114,626 | $8,593,766 | 4.07% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $11,636,348 | 1.44% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,710,339 | $20,896,714 | 0.80% |
| Duquesne Family Office | 1,385,950 | $10,685,675 | 0.53% |
| ALLEN OPERATIONS LLC | 217,657 | $1,678,135 | 0.45% |
| Artal Group S.A. | 960,204 | $7,403 | 0.41% |